Metoprolol Succinate Extended-Release Tablets
» Metoprolol Succinate Extended-Release Tablets contain not less than 90.0 percent and not more than 110.0 percent of the labeled amount of metoprolol succinate [(C15H25NO3)2·C4H6O4].
Packaging and storage— Preserve in tight containers, and store at controlled room temperature.
Labeling— Label it to indicate the content of metoprolol succinate and its equivalent, expressed as metoprolol tartrate (C15H25NO3)2·C4H6O6.
USP Reference standards 11
USP Metoprolol Succinate RS Click to View Structure
Identification—
A: Infrared Absorption 197K
Test specimen— Transfer one or more Tablets, equivalent to about 200 mg of metoprolol succinate, to a stoppered centrifuge tube. Add about 40 mL of pH 6.8 phosphate buffer (see Buffer Solutions in the section Reagents, Indicators, and Solutions) and 40 mL of methylene chloride, and shake for 5 minutes. Centrifuge, filter, and use the aqueous phase as the Test solution. Transfer 3 mL of the Test solution to a separator, add 2 mL of ammonium hydroxide, and extract with 20 mL of methylene chloride. Filter the methylene chloride phase. Grind 1 mL of the filtrate with 300 mg of potassium bromide, dry in a current of warm air, and prepare a disk: the IR spectrum of the Test specimen exhibits maxima only at the same wavelengths as that obtained from a similar preparation of USP Metoprolol Succinate RS (presence of metoprolol).
B: Infrared Absorption 197K
Test specimen— Transfer 5 mL of the Test solution prepared as directed for Identification test A to a glass-stoppered test tube, add 2 mL of 5 N hydrochloric acid, and extract with 5 mL of ether. Filter the ether phase. Grind 2 mL of the filtrate with 300 mg of potassium bromide, dry in a current of warm air, and prepare a disk: the IR spectrum of the Test specimen exhibits maxima only at the same wavelengths as that obtained from a similar preparation of succinic acid (presence of succinate).
Dissolution 711
Medium: pH 6.8 phosphate buffer (see Buffer Solutions in the section Reagents, Indicators, and Solutions); 500 mL.
Apparatus 2: 50 rpm.
Times: 1, 4, 8, and 20 hours.
Determine the amount of (C15H25NO3)2·C4H6O4 dissolved by employing the following method.
pH 3.0 Phosphate buffer, Mobile phase, and Standard solution— Proceed as directed in the test for Uniformity of dosage units.
Procedure— Proceed as directed in the test for Uniformity of dosage units, except to use 5.0 mL of a filtered portion of the solution under test as the Test solution, and Medium as the blank, in comparison with a Standard solution having a known concentration of USP Metoprolol Succinate RS in the same Medium.
Tolerances— The percentages of the labeled amount of (C15H25NO3)2·C4H6O4 dissolved at the times specified conform to Acceptance Table 2.
Time (hours) Amount dissolved
1 not more than 25%
4 between 20% and 40%
8 between 40% and 60%
20 not less than 80%
Uniformity of dosage units 905: meet the requirements.
procedure for content uniformity—
pH 3.0 Phosphate buffer— Mix 50 mL of 1 M monobasic sodium phosphate and 8.0 mL of 1 M phosphoric acid, and dilute with water to 1000 mL. If necessary, adjust with 1 M monobasic potassium phosphate or 1 M phosphoric acid to a pH of 3.0.
Mobile phase— Prepare a filtered and degassed mixture of pH 3.0 Phosphate buffer and acetonitrile (375:125). Make adjustments if necessary (see System Suitability under Chromatography 621).
Standard solution— Dissolve a quantity of USP Metoprolol Succinate RS, accurately weighed, in Mobile phase to obtain a solution having a known concentration of about 0.05 mg per mL.
Test stock solution— Transfer 1 Tablet, accurately weighed, to a volumetric flask of suitable capacity to obtain a solution having a concentration of about 1 mg per mL of metoprolol succinate. Add about 5 mL of water, and allow the Tablet to disintegrate. Add a volume of alcohol such that when diluted to volume, the concentration of alcohol is 30%. Shake for 30 minutes. Add a portion of 0.1 N hydrochloric acid equivalent to about one half of the flask volume, and shake for 30 minutes. Dilute with 0.1 N hydrochloric acid to volume, and mix.
Test solution— Filter the Test stock solution, and discard the first 10 mL of the filtrate. Dilute the filtrate quantitatively with Mobile phase to obtain a solution containing about 0.05 mg per mL of metoprolol succinate.
Chromatographic system (see Chromatography 621)— The liquid chromatograph is equipped with a 280-nm detector and a 4-mm × 12.5-cm column that contains packing L7. The flow rate is about 1 mL per minute. Chromatograph the Standard solution, and record the peak responses as directed for Procedure: the relative standard deviation for replicate injections is not more than 2.0%.
Procedure— Separately inject equal volumes (about 40 µL) of the Standard solution and the Test solution into the chromatograph, record the chromatograms, and measure the responses for the major peaks. Calculate the quantity, in mg, of metoprolol succinate (C15H25NO3)2·C4H6O4 in the Tablet taken by the formula:
20CV(rU / rS)
in which C is the concentration, in mg per mL, of USP Metoprolol Succinate RS in the Standard solution; V is the volume of the Test stock solution used to prepare the Test solution; and rU and rS are the peak responses obtained from the Test solution and the Standard solution, respectively.
Assay— Determine the mean value of the quantity, in mg, of metoprolol succinate [(C15H25NO3)2·C4H6O4] in the Tablets analyzed in the test for Uniformity of dosage units.
Auxiliary Information— Please check for your question in the FAQs before contacting USP.
Topic/Question Contact Expert Committee
Monograph Sujatha Ramakrishna, Ph.D.
Senior Scientific Liaison
1-301-816-8349
(SM22010) Monographs - Small Molecules 2
Reference Standards RS Technical Services
1-301-816-8129
rstech@usp.org
711 Margareth R.C. Marques, Ph.D.
Senior Scientific Liaison
1-301-816-8106
(GCDF2010) General Chapters - Dosage Forms
USP35–NF30 Page 3898
Pharmacopeial Forum: Volume No. 31(1) Page 165